These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17671978)

  • 1. The conformation of the extracellular binding domain of Death Receptor 5 in the presence and absence of the activating ligand TRAIL: a molecular dynamics study.
    Wassenaar TA; Quax WJ; Mark AE
    Proteins; 2008 Feb; 70(2):333-43. PubMed ID: 17671978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation.
    Mongkolsapaya J; Grimes JM; Chen N; Xu XN; Stuart DI; Jones EY; Screaton GR
    Nat Struct Biol; 1999 Nov; 6(11):1048-53. PubMed ID: 10542098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.
    Kim YH; Jung EM; Lee TJ; Kim SH; Choi YH; Park JW; Park JW; Choi KS; Kwon TK
    Free Radic Biol Med; 2008 Mar; 44(6):1055-68. PubMed ID: 18164688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells.
    Chen S; Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY
    Mol Pharmacol; 2007 Nov; 72(5):1269-79. PubMed ID: 17684158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of new TRAIL mutants DR5-A and DR5-B with improved selectivity to death receptor 5.
    Gasparian ME; Chernyak BV; Dolgikh DA; Yagolovich AV; Popova EN; Sycheva AM; Moshkovskii SA; Kirpichnikov MP
    Apoptosis; 2009 Jun; 14(6):778-87. PubMed ID: 19412666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation.
    Kim EH; Yoon MJ; Kim SU; Kwon TK; Sohn S; Choi KS
    Cancer Res; 2008 Jan; 68(1):266-75. PubMed ID: 18172319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5.
    Zhang Y; Zhang B
    Mol Cancer Res; 2008 Dec; 6(12):1861-71. PubMed ID: 19074831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of a novel octamer peptide, CNSCWSKD, that induces caspase-dependent cell death.
    Kaga C; Okochi M; Nakanishi M; Hayashi H; Kato R; Honda H
    Biochem Biophys Res Commun; 2007 Nov; 362(4):1063-8. PubMed ID: 17822671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of antitumor properties of rhTRAIL by affinity increase toward its death receptors.
    Reis CR; van der Sloot AM; Szegezdi E; Natoni A; Tur V; Cool RH; Samali A; Serrano L; Quax WJ
    Biochemistry; 2009 Mar; 48(10):2180-91. PubMed ID: 19236007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of DR5 by proteasome inhibitors potently sensitizes glioma cells to TRAIL-induced apoptosis.
    Hetschko H; Voss V; Seifert V; Prehn JH; Kögel D
    FEBS J; 2008 Apr; 275(8):1925-36. PubMed ID: 18341587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of IG20 splice variants in TRAIL resistance.
    Prabhakar BS; Mulherkar N; Prasad KV
    Clin Cancer Res; 2008 Jan; 14(2):347-51. PubMed ID: 18223207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apple procyanidins activate apoptotic signaling pathway in human colon adenocarcinoma cells by a lipid-raft independent mechanism.
    Maldonado-Celis ME; Bousserouel S; Gossé F; Lobstein A; Raul F
    Biochem Biophys Res Commun; 2009 Oct; 388(2):372-6. PubMed ID: 19666002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogen peroxide enhances TRAIL-induced cell death through up-regulation of DR5 in human astrocytic cells.
    Kwon D; Choi K; Choi C; Benveniste EN
    Biochem Biophys Res Commun; 2008 Aug; 372(4):870-4. PubMed ID: 18534188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells.
    Taniguchi H; Yoshida T; Horinaka M; Yasuda T; Goda AE; Konishi M; Wakada M; Kataoka K; Yoshikawa T; Sakai T
    Cancer Res; 2008 Nov; 68(21):8918-27. PubMed ID: 18974136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand.
    Yasuda T; Yoshida T; Goda AE; Horinaka M; Yano K; Shiraishi T; Wakada M; Mizutani Y; Miki T; Sakai T
    Mol Cancer Res; 2008 Dec; 6(12):1852-60. PubMed ID: 19074830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over-expression of Reticulon 3 (RTN3) enhances TRAIL-mediated apoptosis via up-regulation of death receptor 5 (DR5) and down-regulation of c-FLIP.
    Lee JT; Lee TJ; Kim CH; Kim NS; Kwon TK
    Cancer Lett; 2009 Jul; 279(2):185-92. PubMed ID: 19250737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting pro-apoptotic trail receptors sensitizes HeLa cervical cancer cells to irradiation-induced apoptosis.
    Maduro JH; de Vries EG; Meersma GJ; Hougardy BM; van der Zee AG; de Jong S
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):543-52. PubMed ID: 18793956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 up-regulation and proteasome-mediated c-FLIPS down-regulation.
    Kim JY; Kim EH; Park SS; Lim JH; Kwon TK; Choi KS
    J Cell Biochem; 2008 Dec; 105(6):1386-98. PubMed ID: 18980244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL.
    Wagner KW; Punnoose EA; Januario T; Lawrence DA; Pitti RM; Lancaster K; Lee D; von Goetz M; Yee SF; Totpal K; Huw L; Katta V; Cavet G; Hymowitz SG; Amler L; Ashkenazi A
    Nat Med; 2007 Sep; 13(9):1070-7. PubMed ID: 17767167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The promise of cancer therapeutics targeting the TNF-related apoptosis-inducing ligand and TRAIL receptor pathway.
    Wang S
    Oncogene; 2008 Oct; 27(48):6207-15. PubMed ID: 18931688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.